Surgical treatment of ductal pancreatic carcinoma

Eur J Surg Oncol. 1991 Apr;17(2):173-81.


Among 587 patients with ductal pancreatic carcinoma who were examined between 1969 and 1987, 260 (44.3%) had distant metastases at the time of diagnosis. Tumour resections, mostly subtotal duodenopancreatectomies, were performed in 138 patients (23.5% of all patients, or 39.8% of all patients without distant metastases); in 91 patients the resection was for cure (R0). Operative mortality following tumour resection was 6% for all patients. The age-corrected 5-year survival rate was 2.9% for all patients and 16% where the resection was curative; of these 46% were in Stages I and II and 6% in Stage III. In non-curative resections, the median survival time was 7.2 months, which was significantly longer than the 3.4 months following bypass operation. Cure for pancreatic carcinoma can be achieved only through surgery, and a negative attitude towards surgery must be resisted.

MeSH terms

  • Carcinoma / mortality
  • Carcinoma / pathology
  • Carcinoma / surgery*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Ducts*
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery*
  • Prognosis
  • Retrospective Studies
  • Surgical Procedures, Operative / adverse effects
  • Surgical Procedures, Operative / methods
  • Survival Rate